You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
IFR:CRO公司Novotech計劃在香港進行15億美元的IPO
uSMART盈立智投 03-05 14:55

彭博報道,IFR援引不具名人士報道,擁有TPG支持的臨牀研究和檢測提供商Novotech計劃今年在香港首次公開募股(IPO),可能籌資約15億美元。

這家總部悉尼的公司正與高盛和瑞銀合作籌劃發行事宜。

公司目標IPO估值超過40億美元。

尚未確定發行細節,交易規模可能仍會發生變化。

NOVOTECH:全球領先的CRO公司

NOVOTECH是全球業內廣泛認可的領先地區全方位服務合同研究組織(CRO)。

Novotech在臨牀試驗及治療領域全過程各階段提供臨牀發展服務,包括:可行性評估、倫理委員會及監管遞交、數據管理、統計分析、醫療監管、安全服務、中央實驗室服務、根據ICH要求撰寫報告、項目及供應商管理等等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account